Accordingly neuronal activity has been reported to be potentially involved in glioma progression, via the activity of neuroligin-3 (NLGN-3), which appears to promote tumour progression through, at least partly, the PI3K-mTOR pathway, with links to focal adhesion kinase activation [76]. This evidence concerns the gene NLGN3 and central nervous system cancer.